Outset Medical, Inc. Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)
Outset Medical, Inc. (OM) reported Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) of $1.43 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net
us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease · last filed 2026-08-06
- Outset Medical, Inc. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2026-06-30 was $1.14M, a 20.35% decline year-over-year.
- Outset Medical, Inc. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2026-03-31 was $297.00K, a 50.76% increase year-over-year.
- Outset Medical, Inc. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2025-12-31 was $2.87M, a 411.61% increase year-over-year.
- Outset Medical, Inc. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Outset Medical, Inc. accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2024 was $2.38M.
| Period end | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 3 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 6 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 9 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.43M 10-Q · filed 2026-08-06 | $4.30M derived: sum of 3 quarters · filed 2026-08-06 | $4.30M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $297.00K 10-Q · filed 2026-05-07 | $3.16M derived: sum of 2 quarters · filed 2026-08-06 | $3.16M derived: sum of 3 quarters · filed 2026-08-06 | $4.59M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $2.87M derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-06 | $2.87M derived: sum of 2 quarters · filed 2026-08-06 | $4.29M derived: sum of 3 quarters · filed 2026-08-06 | $4.49M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.43M derived: sum of 2 quarters · filed 2025-11-10 | $1.62M 10-Q · filed 2025-11-10 | $2.18M derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-06-30 | $1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.62M 10-Q · filed 2025-08-07 | $2.18M derived: sum of 3 quarters · filed 2026-02-13 | $2.18M derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-03-31 | $197.00K 10-Q · filed 2025-05-08 | $757.00K derived: sum of 2 quarters · filed 2026-02-13 | $758.00K derived: sum of 3 quarters · filed 2026-02-13 | |
| 2024-12-31 | $560.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $561.00K derived: sum of 2 quarters · filed 2026-02-13 | $2.38M 10-K · filed 2026-02-13 | |
| 2024-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.82M 10-Q · filed 2024-11-07 | ||
| 2024-06-30 | $1.82M 10-Q · filed 2024-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |